insights_auto
Hvorfor har CSBR gått ned? 3,30%?
Gå mer i dybdenchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,44 USD
arrow_downward
−3,30%(−0,15) 1 D
18. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,55 USD
Høy
4,60 USD
Lav
4,41 USD
Markedsverdi
61,82 mill.
Snittvolum
7,41k
Volum
0,00
52 u høy
8,31 USD
52 u lav
4,41 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,55 USD
Høy
4,60 USD
Lav
4,41 USD
Markedsverdi
61,82 mill.
Snittvolum
7,41k
Volum
0,00
52 u høy
8,31 USD
52 u lav
4,41 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
Yahoo Finance
·
for 2 timer siden
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Barron's
·
for 7 timer siden
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
Hedgeye
·
for 17 timer siden
Why Negative Gamma Has Taken the Brakes Off the S&P 500
The Motley Fool
·
for 3 timer siden
The S&P 500 Just Ended a Run of 155 Trading Days Above Its 200-Day Average. Here's What Followed 34 Similar Runs Since 1950.
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com